IP16-14MEK1 AS A SYNTHETIC LETHAL TARGET WITH CABOZANTINIB IN RENAL CELL CARCINOMA: INSIGHTS FROM CRISPR/CAS9 SCREENING doi:10.1097/01.JU.0001110024.72300.75.14Wolters KluwerThe Journal of UrologyHirofumi YoshinoKagoshimaJapanYusuke GotoNaohiko SekiHideki Enokida...